Pfizer Vax Safe, Even Among the Highly Allergic

(MedPage Today) -- Most highly allergic adults were able to safely receive the two-dose series of the Pfizer/BioNTech COVID-19 vaccine (BNT162b2; Comirnaty), a prospective single-center study found.
Of 429 highly allergic patients who received...